Involvement of vasopressin V1b receptor in anti-anxiety action of SSRI and SNRI in mice

Neuroscience Research

Volumn 66, Issue 3, 2010, Pages 233-237

  Ishizuka, Yuta ^a   Abe, Hiroshi ^a   Tanoue, Akito ^b   Kannan, Hiroshi ^c   Ishida, Yasushi ^a  

^a UNIVERSITY OF MIYAZAKI   (Japan)

^b NATIONAL RESEARCH INSTITUTE FOR CHILD HEALTH AND DEVELOPMENT   (Japan)

^c KYUSHU WOMEN'S UNIVERSITY   (Japan)

Author keywords

Anxiety behavior; Knockout mice; Serotonin; Vasopressin V1b receptor

Indexed keywords

1 [5 CHLORO 1 (2,4 DIMETHOXYLPHENYLSULFONYL) 2,3 DIHYDRO 3 (2 METHOXYPHENYL) 2 OXO 1H INDOL 3 YL] 4 HYDROXY N,N DIMETHYL 2 PYRROLIDINECARBOXAMIDE; FLUVOXAMINE; MILNACIPRAN; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; VASOPRESSIN RECEPTOR ANTAGONIST; VASOPRESSIN V1B RECEPTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY; ARTICLE; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; EXPERIMENTAL TEST; HOLE BOARD TEST; MALE; MAZE TEST; MOUSE; NONHUMAN; PRIORITY JOURNAL; REARING; TRANQUILIZING ACTIVITY;

ANIMALS; ANXIETY; INDOLES; MALE; MAZE LEARNING; MICE; MICE, KNOCKOUT; MOTOR ACTIVITY; NEUROPSYCHOLOGICAL TESTS; NEUROTRANSMITTER UPTAKE INHIBITORS; PYRROLIDINES; RECEPTORS, VASOPRESSIN; SEROTONIN; SEROTONIN UPTAKE INHIBITORS; TIME FACTORS;

EID: 77049101161     PISSN: 01680102     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neures.2009.11.004     Document Type: Article

References (32)

1. Bhatnagar S., Sun L.M., Raber J., Maren S., Julius D., Dallman M.F. Changes in anxiety-related behaviors and hypothalamic-pituitary-adrenal activity in mice lacking the 5-HT-3A receptor. Physiol. Behav. 2004, 81:545-555.
2. Buwalda B., Nyakas C., Koolhaas J.M., Bohus B. Effects of neonatal administration of vasopressin on cardiac and behavioral responses to emotional stress in adult male rats. Physiol. Behav. 1991, 50:929-932.
3. Coccaro E.F. Clinical outcome of psychopharmacologic treatment of borderline and schizotypal personality disordered subjects. J. Clin. Psychiatry 1998, 59(Suppl. 1):30-35. discussion 36-37. Review.
4. Coccaro E.F., Kavoussi R.J., Hauger R.L., Cooper T.B., Ferris C.F. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch. Gen. Psychiatry 1998, 55:708-714.
5. Compaan J.C., Buijs R.M., Pool C.W., De Ruiter A.J., Koolhaas J.M. Differential lateral septal vasopressin innervation in aggressive and nonaggressive male mice. Brain Res. Bull. 1993, 30:1-6.
6. Crawley J.N. Behavioral phenotyping of rodents. Comp. Med. 2003, 53:140-146. Review.
7. Delville Y., Mansour K.M., Ferris C.F. Serotonin blocks vasopressin-facilitated offensive aggression: interactions within the ventrolateral hypothalamus of golden hamsters. Physiol. Behav. 1996, 59:813-816.
8. Ferris C.F. Serotonin diminishes aggression by suppressing the activity of the vasopressin system. Ann. N.Y. Acad. Sci. 1996, 794:98-103.
9. Ferris C.F. Adolescent stress and neural plasticity in hamsters: a vasopressin-serotonin model of inappropriate aggressive behaviour. Exp. Physiol. 2000, 85. (Spec. 85-90. Review).
10. Ferris C.F., Delville Y. Vasopressin and serotonin interactions in the control of agonistic behavior. Psychoneuroendocrinology 1994, 19:593-601. Review.
11. Ferris C.F., Melloni R.H., Koppel G., Perry K.W., Fuller R.W., Delville Y. Vasopressin/serotonin interactions in the anterior hypothalamus control aggressive behavior in golden hamsters. J. Neurosci. 1997, 17:4331-4340.
12. Ferris C.F., Potegal M. Vasopressin receptor blockade in the anterior hypothalamus suppresses aggression in hamsters. Physiol. Behav. 1988, 44:235-239.
13. Ferris C.F., Stolberg T., Delville Y. Serotonin regulation of aggressive behavior in male golden hamsters (Mesocricetus auratus). Behav. Neurosci. 1999, 113:804-815.
14. Gardier A.M., Malagié I., Trillat A.C., Jacquot C., Artigas F. Role of 5-HT1A autoreceptors in the mechanism of action of serotoninergic antidepressant drugs: recent findings from in vivo microdialysis studies. Fundam. Clin. Pharmacol. 1996, 10:16-27. (Review).
15. Hernando F., Schoots O., Lolait S.J., Burbach J.P. Immunohistochemical localization of the vasopressin V1b receptor in the rat brain and pituitary gland: anatomical support for its involvement in the central effects of vasopressin. Endocrinology 2001, 142:1659-1668.
16. Hodgson R.A., Higgins G.A., Guthrie D.H., Lu S.X., Pond A.J., Mullins D.E., Guzzi M.F., Parker E.M., Varty G.B. Comparison of the V1b antagonist, SSR149415, and the CRF1 antagonist, CP-154,526, in rodent models of anxiety and depression. Pharmacol. Biochem. Behav. 2007, 86:431-440.
17. Invernizzi R.W., Garattini S. Role of presynaptic alpha2-adrenoceptors in antidepressant action: recent findings from microdialysis studies. Prog. Neuropsychopharmacol. Biol. Psychiatry 2004, 28:819-827.
18. Jard S. Vasopressin receptors. A historical survey. Adv. Exp. Med. Biol. 1998, 449:1-13. Review.
19. Jard S., Barberis C., Audigier S., Tribollet E. Neurohypophyseal hormone receptor systems in brain and periphery. Prog. Brain Res. 1987, 72:173-187. (Review).
20. Kruesi M.J., Rapoport J.L., Hamburger S., Hibbs E., Potter W.Z., Lenane M., Brown G.L. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiatry 1990, 47:419-426.
21. Landgraf R., Neumann I.D. Vasopressin and oxytocin release within the brain: a dynamic concept of multiple and variable modes of neuropeptide communication. Front. Neuroendocrinol. 2004, 25:150-176. (Review).
22. Li X.B., Inoue T., Hashimoto S., Koyama T. Effect of chronic administration of flesinoxan and fluvoxamine on freezing behavior induced by conditioned fear. Eur. J. Pharmacol. 2001, 425:43-50.
23. Linnoila M., Virkkunen M., Scheinin M., Nuutila A., Rimon R., Goodwin F.K. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from nonimpulsive violent behavior. Life Sci. 1983, 33:2609-2614.
24. Lolait S.J., O'Carroll A.M., Mahan L.C., Felder C.C., Button D.C., Young W.S., Mezey E., Brownstein M.J. Extrapituitary expression of the rat V1b vasopressin receptor gene. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:6783-6787.
25. Moojen V.K., Martins M.R., Reinke A., Feier G., Agostinho F.R., Cechin E.M., Quevedo J. Effects of milnacipran in animal models of anxiety and memory. Neurochem. Res. 2006, 31:571-577.
26. Raap D.K., Van de Kar L.D. Selective serotonin reuptake inhibitors and neuroendocrine function. Life Sci. 1999, 65:1217-1235. (Review).
27. Serradeil-Le Gal C., Wagnon J., Simiand J., Griebel G., Lacour C., Guillon G., Barberis C., Brossard G., Soubrié P., Nisato D., Pascal M., Pruss R., Scatton B., Maffrand J.P., Le Fur G. Characterization of (2S,4R)-1-[5-chloro-1-[(2,4-dimethoxyphenyl)sulfonyl]-3-(2-methoxy-phenyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-4-hydroxy-N,N-dimethyl-2-pyrrolidine carboxamide (SSR149415), a selective and orally active vasopressin V1b receptor antagonist. J. Pharmacol. Exp. Ther. 2002, 300:1122-1130.
28. Sijbesma H., Schipper J., de Kloet E.R., Mos J., van Aken H., Olivier B. Postsynaptic 5-HT1 receptors and offensive aggression in rats: a combined behavioural and autoradiographic study with eltoprazine. Pharmacol. Biochem. Behav. 1991, 38:447-458.
29. Tanoue A., Ito S., Honda K., Oshikawa S., Kitagawa Y., Koshimizu T.A., Mori T., Tsujimoto G. The vasopressin V1b receptor critically regulates hypothalamic-pituitary-adrenal axis activity under both stress and resting conditions. J. Clin. Invest. 2004, 113:302-309.
30. Thibonnier M. Vasopressin and blood pressure. Kidney Int. Suppl. 1988, 25:52-56. Review.
31. Virkkunen M., Goldman D., Nielsen D.A., Linnoila M. Low brain serotonin turnover rate (low CSF 5-HIAA) and impulsive violence. J. Psychiatry Neurosci. 1995, 20:271-275. (Review).
32. Young W.S., Li J., Wersinger S.R., Palkovits M. The vasopressin 1b receptor is prominent in the hippocampal area CA2 where it is unaffected by restraint stress or adrenalectomy. Neuroscience 2006, 143:1031-1039.